The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Slides:

Advertisements

Similar presentations

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Advertisements

Education in vascular surgery: Critical issues in India

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Without prejudice Journal of Vascular Surgery

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

A patient with multiple paradoxical emboli

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Stenting of femoropopliteal lesions using interwoven nitinol stents

Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score Daniel M. Ihnat,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions Wei Ye, MD, Chang-Wei Liu,

Danielle B. Cameron, BA, James H. Black, MD, Elliot K

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr

Mohamed A. Zayed, MD, PhD, Ronald L. Dalman, MD, Jason T. Lee, MD

Endovascular management of TransAtlantic Inter-Society Consensus D iliac artery occlusion secondary to radiation arteritis Jonathan Lee, BS, Palma Shaw,

Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients Christopher D.

The first operation on the profunda femoris artery

Using distal revascularization with interval ligation as the primary treatment of hand ischemia after dialysis access creation Rahim Aimaq, MD, Steven.

Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions Michele.

Without prejudice Journal of Vascular Surgery

PC180. Iliac-femoral Post-Thrombotic Syndrome: Three-Dimensional CT Venography for Preintervention Evaluation and Midterm Stent Patency Follow-up Minyi.

Michael S. Conte, MD Journal of Vascular Surgery

Magdiel Trinidad-Hernandez, MD, Joseph J

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting? Richard.

Education in vascular surgery: Critical issues in India

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Effect of perioperative complications after endovascular therapy in patients with peripheral artery disease due to femoropopliteal lesions Kei Sato,

Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD

Vincent L. Rowe, MD, William Lee, MD, Fred A

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts Ahsan T. Ali, MD, J. Gregory Modrall,

Syed N. Haider, Eamon G. Kavanagh, MD, Martin Forlee, FCS (SA), Mary P

Infrainguinal cutting balloon angioplasty in de novo arterial lesions

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Sadaf S. Ahanchi, MD, Christopher L. Stout, MD, Tyler J

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Ryan M. Svoboda, Kristina A. Giles, Samantha A. Connell, Daniel B

Primary stenting of the superficial femoral and popliteal artery

Balloon angioplasty for revision of failing lower extremity bypass grafts Haitham Ali, MD, Ahmed Elbadawy, MD, Mahmoud Saleh, MD, Ayman Hasaballah, MD

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Ilia Gur, MD, William Lee, MD, Gabriel Akopian, MD, Vincent L

Reply Journal of Vascular Surgery

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

The influence of gender on patency rates after iliac artery stenting

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Reviewer Acknowledgment

Plaque excision with the Silverhawk catheter: Early results in patients with claudication or critical limb ischemia W. Brent Keeling, MD, Murray L. Shames,

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Complications of iliac artery stent deployment

Charles S. Joels, MD, John W. York, MD, Corey A. Kalbaugh, MS, David L

Endovascular repair of an acute blunt popliteal artery injury

Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery Luis R. León, MD, RVT, Robert.

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Homologous veins as an arterial substitute: Long-term results

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis Brian Nolan, MD,

Determinants of successful peroneal artery bypass

Endovascular interventions for TASC II D femoropopliteal lesions

Endovascular brachytherapy for renal artery in-stent restenosis

Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria Kristina A. Giles, MD, Allen D. Hamdan,

Iliac artery stenting versus surgical reconstruction for TASC (transatlantic inter-society consensus) type B and type C iliac lesions Carlos H Timaran,

Thigh claudication due to profunda femoris artery occlusion

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Surgical management of popliteal artery aneurysms: Which factors affect outcomes? Raffaele Pulli, MD, Walter Dorigo, MD, Nicola Troisi, MD, Alessandro.

Presentation transcript:

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD, Steven G. Katz, MD Journal of Vascular Surgery Volume 55, Issue 4, Pages 994-1000 (April 2012) DOI: 10.1016/j.jvs.2011.10.106 Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 1 Primary patency grouped by TransAtlantic Inter-Society Consensus (TASC) A and B vs C and D lesions. Months 0 20 40 60 Number at risk (TASC A, B) 202 31 7 1 Number at risk (TASC C, D) 87 18 3 1 Journal of Vascular Surgery 2012 55, 994-1000DOI: (10.1016/j.jvs.2011.10.106) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 2 Primary patency vs good (two or three vessel) vs poor (zero or one vessel) runoff Months 0 20 40 60 Number at risk with 0 or 1 vessel runoff 202 28 4 0 Number at risk with 2 or 3 vessel runoff 87 22 6 3 Journal of Vascular Surgery 2012 55, 994-1000DOI: (10.1016/j.jvs.2011.10.106) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 3 Primary patency vs number of runoff vessels Months 0 20 40 60 Number at risk with 0 runoff vessels 14 0 0 0 Number at risk with 1 runoff vessel 131 28 4 0 Number at risk with 2 runoff vessels 88 14 4 1 Number at risk with 3 runoff vessels 56 8 2 0 Journal of Vascular Surgery 2012 55, 994-1000DOI: (10.1016/j.jvs.2011.10.106) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 4 Primary patency vs modified Society of Vascular Surgery (SVS) runoff score of 0 to 5 or >5 Months 0 20 40 60 Number at risk with runoff score 0-5 130 19 4 1 Number at risk with runoff score >5 159 30 4 1 Journal of Vascular Surgery 2012 55, 994-1000DOI: (10.1016/j.jvs.2011.10.106) Copyright © 2012 Society for Vascular Surgery Terms and Conditions